Edward Barsegyan, PMHNP
Psychiatric/Mental Health · Glendale
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Edward Barsegyan’s office at (818) 642-5554 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$10,146
Medicare paid this office $10,146 for 126 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit | 109 | $7,079 | $25 |
| Psychiatric diagnostic evaluation with medical services | 23 | $2,717 | $118 |
Who their Medicare patients are
126 Original Medicare patients in 2024. Average age 87 · 85 and older 69% · Women 79% · Health risk score 2.10. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Coronary heart disease 75% · Depression 75% · Dementia 75% · Heart failure 67% · Diabetes 52% · Chronic kidney disease 46% · Atrial fibrillation 37% · COPD 30% · Stroke 11% · Cancer 9%.
The office billed $113,350, Medicare allowed $12,734 and paid $10,146; for 314 services of 3 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Medicaid work
$21,854 in 2024
Medicaid paid $21,854 for 176 billed services this clinician did in 2024, up to 76 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 129 | $21,786 |
| Short return visit | 47 | $69 |
| 2024 | 176 | 2 | 76 | $21,854 |
Drugs they prescribed that Part D paid
$23,034
Pharmacies billed $23,034 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 268) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
250 generic and 18 brand-name prescriptions · $23,034 in drug cost · 57 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Quetiapine | 24 | $287 | $12 |
| Aripiprazole | 21 | $196 | $9 |
| Escitalopram | 29 | $167 | $6 |
| Olanzapine | 13 | $137 | $11 |
| Mirtazapine | 13 | $80 | $6 |
See all 9 drugs
| Quetiapine | 24 | $287 | $12 |
| Aripiprazole | 21 | $196 | $9 |
| Escitalopram | 29 | $167 | $6 |
| Olanzapine | 13 | $137 | $11 |
| Mirtazapine | 13 | $80 | $6 |
| Buspirone | 17 | $57 | $3 |
| Lorazepam | 13 | $50 | $4 |
| Trazodone | 14 | $36 | $3 |
| Citalopram Hbr | 26 | $27 | $1 |
Money from drug and device companies
$458 in 2025
| 2025 | 5 | 18 | None | $458 |
| 2024 | 4 | 6 | None | $171 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| ViiV Healthcare | Dovato | $298 | 11 payments
|
| Abbvie | Vraylar | $78 | 4 payments
|
| Merck Sharp & Dohme | Pifeltro | $29 | 1 payment
|
| Janssen Pharmaceuticals | Spravato | $27 | 1 payment
|
| Otsuka America Pharmaceutical | Abilify Asimtufii | $26 | 1 payment
|
See all 18 published payments
| Abbvie | Meals · 2025-10-21 | Vraylar | $27 |
| Otsuka America Pharmaceutical | Meals · 2025-10-13 | Abilify Asimtufii | $26 |
| ViiV Healthcare | Meals · 2025-05-02 | Dovato | $14 |
| ViiV Healthcare | Meals · 2025-04-15 | Dovato | $13 |
| ViiV Healthcare | Meals · 2025-04-02 | Dovato | $28 |
| ViiV Healthcare | Meals · 2025-04-02 | Dovato | $0 |
| Abbvie | Meals · 2025-03-13 | Vraylar | $23 |
| ViiV Healthcare | Meals · 2025-03-05 | Cabenuva | $125 |
| ViiV Healthcare | Meals · 2025-03-04 | Dovato | $24 |
| ViiV Healthcare | Meals · 2025-03-04 | Dovato | $3 |
| Janssen Pharmaceuticals | Meals · 2025-02-26 | Spravato | $27 |
| ViiV Healthcare | Meals · 2025-02-18 | Dovato | $10 |
| Abbvie | Meals · 2025-02-18 | Vraylar | $14 |
| ViiV Healthcare | Meals · 2025-02-04 | Dovato | $29 |
| ViiV Healthcare | Meals · 2025-02-03 | Apretude | $28 |
| Abbvie | Meals · 2025-01-22 | Vraylar | $14 |
| Merck Sharp & Dohme | Meals · 2025-01-14 | Pifeltro | $29 |
| ViiV Healthcare | Meals · 2025-01-10 | Dovato | $24 |
See earlier years (2024)
2024: $171
| Lundbeck | Rexulti | $65 | 2 payments
|
| Abbvie | Vraylar | $61 | 2 payments
|
| Otsuka America Pharmaceutical | Abilify Asimtufii | $24 | 1 payment
|
| ViiV Healthcare | Dovato | $21 | 1 payment
|
Professional record
- NPI
- 1407624927
- Licence
- CA 95028287
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X)
- Mailing address
- 7463 Lemp Ave, North Hollywood, CA, 91605
- NPI first listed
- 2023-12-14
- NPI last updated
- 2023-12-14
- NPI record certified
- 2023-12-13
This is when the NPI record was last certified, not a medical board exam.